L. Pache
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms 9
- Immunology and Allergy top 2%
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 8
- Oncology top 5%
- Peptidase Inhibition and Analysis 4
- Hematology top 5%
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 4
-
- Intraperitoneal and Appendiceal Malignancies 3
-
- Lung Cancer Treatments and Mutations 3
-
- Breast Lesions and Carcinomas 2
-
- Endometrial and Cervical Cancer Treatments 2
- Co-authors
- F. JänickeH. GraeffManfred SchmittNadia HarbeckHeinz HöflerP. DettmarKurt UlmMichael Untch
- Partner nations
- GermanySwitzerlandEstonia
In The Last Decade
L. Pache
20 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 74
- Cancer Research 843
- Immunology and Allergy 227
- Reproductive Medicine 281
- Oncology 615
- Hematology 246
Countries citing papers authored by L. Pache
This map shows the geographic impact of L. Pache's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Pache with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Pache more than expected).
Fields of papers citing papers by L. Pache
This network shows the impact of papers produced by L. Pache. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Pache. The network helps show where L. Pache may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L. Pache, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 22 | |
| 2 | 2008 | 0 | |
| 3 | 1999 | 110 | |
| 4 | 1998 | 45 | |
| 5 | Disease-adapted relapse therapy for ovarian cancer: results of a prospective study. | 1998 | 20 |
| 6 | 1998 | 14 | |
| 7 | 1997 | 65 | |
| 8 | 1997 | 1 | |
| 9 | 1996 | 10 | |
| 10 | Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2. | 1995 | 85 |
| 11 | 1995 | 2 | |
| 12 | Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. | 1995 | 111 |
| 13 | 1994 | 114 | |
| 14 | 1994 | 182 | |
| 15 | 1993 | 298 | |
| 16 | 1993 | 7 | |
| 17 | 1993 | 2 | |
| 18 | 1992 | 105 | |
| 19 | 1992 | 152 | |
| 20 | 1986 | 17 |
About L. Pache
L. Pache is a scholar working on Reproductive Medicine, Cancer Research and Oncology, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Ovarian cancer diagnosis and treatment (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Peptidase Inhibition and Analysis (4 papers), Intraperitoneal and Appendiceal Malignancies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Breast Lesions and Carcinomas (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). The work is most often cited by research in Cancer Research (843 citations), Immunology and Allergy (227 citations) and Reproductive Medicine (281 citations). L. Pache has collaborated with scholars based in Germany, Switzerland and Estonia. Frequent co-authors include F. Jänicke, H. Graeff, Manfred Schmitt, Nadia Harbeck, Heinz Höfler, P. Dettmar, Kurt Ulm, Michael Untch, W. Eiermann and W. Kühn. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, Cancer, Breast Cancer Research and Treatment and International Archives of Occupational and Environmental Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.